Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.
about
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrheaAntimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and futureOrigin and proliferation of multiple-drug resistance in bacterial pathogensGenomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolatesAlarmingly High Segregation Frequencies of Quinolone Resistance Alleles within Human and Animal Microbiomes Are Not Explained by Direct Clinical Antibiotic ExposureImproving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling.Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype.Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure.Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006Drug-resistant Neisseria gonorrhoeae: latest developments.Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.Studying the effect of administration route and treatment dose on the selection of enrofloxacin resistance in commensal Escherichia coli in broilers.Effects of Formulation on Microbicide Potency and Mitigation of the Development of Bacterial Insusceptibility.Resistance Mutations in gyrA and parC are Common in Escherichia Communities of both Fluoroquinolone-Polluted and Uncontaminated Aquatic EnvironmentsAltered Competitive Fitness, Antimicrobial Susceptibility, and Cellular Morphology in a Triclosan-Induced Small-Colony Variant of Staphylococcus aureus.Fluoroquinolone resistance does not impose a cost on the fitness of Clostridium difficile in vitro.Transient and sustained bacterial adaptation following repeated sublethal exposure to microbicides and a novel human antimicrobial peptide.Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach.Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.CDC Grand Rounds: the growing threat of multidrug-resistant gonorrhea.Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.Alanine 501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness.In Vivo-Selected Compensatory Mutations Restore the Fitness Cost of Mosaic penA Alleles That Confer Ceftriaxone Resistance in Neisseria gonorrhoeae.
P2860
Q24633203-AAC6012B-0BFF-45BD-8A2E-0F49AE025A52Q26862597-9E090957-BF11-4C17-A18D-837511124814Q27023284-702F086D-CF18-4B5D-AFCA-869432EAF934Q28914762-488E039B-2D9C-4019-89C6-3E3B024D0822Q33798166-1718FFFA-96F7-43C0-BB81-F736E4587800Q35644230-387712B7-54C3-4BCB-BAA9-4967D2DC3428Q36597767-06753E64-E578-4BB1-AC2C-1B23A45730F5Q36969695-AE24617E-AA40-483F-9082-4FD33E07290AQ37036002-5414BB80-B5CE-4C96-8F87-1A4CB195B0FFQ37074679-5CF82123-225B-47F6-9093-536CD2AB41A8Q37306380-BB03F612-C375-4230-BBA4-B1F6587F6E7EQ37379658-36922660-CDB0-40F9-9CBE-E6C8E4A4B5F2Q37664535-9BE2D528-1745-44B2-9209-885E2F351847Q38756266-9483FD69-4E39-4A5B-A110-7E98ED56F30CQ40118853-0F6EBB4D-4200-48E1-AB76-025A5E7187C2Q40238353-8A82D1C8-5155-4996-8651-4DE742CCD072Q40647006-DA44BBC5-D2A1-4BED-A42E-8E0CBC795B4BQ40860093-7DB7DE98-D8CD-418D-BA86-34139C0B7683Q41190866-FA11CC11-C793-42BC-9E45-81EDCA6CCB41Q41585335-A70A3CBC-258C-4F40-ADE2-ED68562351D1Q42051842-B11C9019-67AB-4158-BFE7-ECBECB343A28Q42367451-9F711C2F-027A-493F-A5F5-6351C96DF896Q42659717-519A5364-682A-47FF-B6BB-D7230AE809CDQ43940429-9E37AE5A-2649-4C6D-8BC8-5429B1F8BA0FQ44038854-566CD528-773F-4C8B-9902-8B9831226F43Q46589487-BFBDD34B-7B03-4DD1-A380-B8351D80015EQ47664492-8E42150D-E6DD-4778-8E43-CD3087F6E6B1Q48289899-83273802-BA31-4A10-B83B-C707A18071D3Q52609076-D69A8DF9-C5C8-438E-93FA-A166362698CC
P2860
Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impact of fluoroquinolone resi ...... on for compensatory mutations.
@ast
Impact of fluoroquinolone resi ...... on for compensatory mutations.
@en
type
label
Impact of fluoroquinolone resi ...... on for compensatory mutations.
@ast
Impact of fluoroquinolone resi ...... on for compensatory mutations.
@en
prefLabel
Impact of fluoroquinolone resi ...... on for compensatory mutations.
@ast
Impact of fluoroquinolone resi ...... on for compensatory mutations.
@en
P2093
P2860
P356
P1476
Impact of fluoroquinolone resi ...... on for compensatory mutations.
@en
P2093
Afrin A Begum
Anjali N Kunz
Ann E Jerse
James M Robinson
Jonathan A D'Ambrozio
Margaret C Bash
William M Shafer
P2860
P304
P356
10.1093/INFDIS/JIS277
P407
P577
2012-04-05T00:00:00Z